Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009

Published:2013-03-13 Issue:5 Volume:27 Page:803-813
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.;Sterne;Lancet,2005

2. HIV Outpatient Study InvestigatorsMortality in the highly active antiretroviral therapy era, changing causes of death and disease in the HIV outpatient study.;Palella;J Acquir Immune Defic Syndr,2006

3. Antiretroviral treatment of Adult HIV infection: 2010 recommendations of the International AIDS Society-USA Panel.;Thompson;JAMA,2010

4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.;Palella;N Engl J Med,1998

5. Clinical practice: management of newly diagnosed HIV infection.;Hammer;N Engl J Med,2005

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China;Nature Communications;2023-09-02

2. Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study;Viruses;2023-03-10

3. New designs for HIV-1 integrase inhibitors: a patent review (2018-present);Expert Opinion on Therapeutic Patents;2023-01-02

4. Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan;Journal of Infection and Chemotherapy;2022-11

5. Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan;Scientific Reports;2022-02-02